cALD
Showing 1 - 18 of 18
Cerebral Adrenoleukodystrophy Trial in Minneapolis (Mesenchymal stem cells (IV-MSC))
Recruiting
- Cerebral Adrenoleukodystrophy
- Mesenchymal stem cells (IV-MSC)
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Sep 7, 2023
Mucopolysaccharidosis Disorders, Hurler Syndrome, Hunter Syndrome Trial in Minneapolis (Stem Cell Transplantation, IMD
Recruiting
- Mucopolysaccharidosis Disorders
- +28 more
- Stem Cell Transplantation
- +7 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Nov 1, 2022
Diversity in Patients With OAB
Not yet recruiting
- Overactive Bladder
- +4 more
- Questionnaires
-
Ghent, East-Fanders, BelgiumGhent University Hospital
Jun 5, 2023
Cerebral Adrenoleukodystrophy (CALD) Trial in Worldwide (Lenti-D)
Active, not recruiting
- Cerebral Adrenoleukodystrophy (CALD)
- Lenti-D
-
Palo Alto, California
- +7 more
Mar 22, 2022
Cerebral Adrenoleukodystrophy (CALD) Trial in Worldwide (Lenti-D Drug Product (eli-cel))
Completed
- Cerebral Adrenoleukodystrophy (CALD)
- Lenti-D Drug Product (eli-cel)
-
Los Angeles, California
- +7 more
Mar 25, 2022
Cerebral Adrenoleukodystrophy (cALD) Trial in Argentina, Brazil, United States (Leriglitazone, Placebo)
Not yet recruiting
- Cerebral Adrenoleukodystrophy (cALD)
- Leriglitazone
- Placebo
-
Palo Alto, California
- +6 more
Apr 5, 2023
Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug
Enrolling by invitation
- Cerebral Adrenoleukodystrophy (CALD)
- +2 more
- Lenti-D
-
Los Angeles, California
- +10 more
Nov 4, 2022
Using Brain Diffusion MRI in X-linked Adrenoleukodystrophy
Not yet recruiting
- X-linked Adrenoleukodystrophy
- brainQuant module of brainTale-care platform
- (no location specified)
Jun 12, 2023
Gynecologic Cancer Trial in Toronto (Questionnaire)
Recruiting
- Gynecologic Cancer
- Questionnaire
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jul 24, 2023
Macrophages Activation Pattern in X-linked Adrenoleukodystrophy,
Recruiting
- Adrenoleukodystrophy
- +3 more
- Blood sample collection
-
Le Kremlin-Bicêtre, France
- +1 more
Oct 10, 2022
Sickle Cell Disease, Thalassemia, High Risk Hematologic Disorders Trial in Minneapolis (Blood and Marrow Transplant)
Recruiting
- Sickle Cell Disease
- +4 more
- Blood and Marrow Transplant
-
Minneapolis, MinnesotaMasonic Caner Center at University of Minnesota
May 23, 2022
Cladribine Therapy After Anti CD20 Therapy
Active, not recruiting
- Multiple Sclerosis
- Cladribine Oral Tablet
- +2 more
-
Lugano, Ticino, SwitzerlandNeurocenter of Southern Switzerland, Ospedale Regionale di Lugan
Mar 22, 2022
AMN, AMN Gene Mutation, X-ALD Trial in Worcester (SBT101, Imitation Procedure)
Recruiting
- AMN
- +2 more
- SBT101
- Imitation Procedure
-
Worcester, MassachusettsUniversity of Massachusetts Chan Medical School
Jun 1, 2022
Inherited Metabolic Disorders Who Underwent Hematopoietic Stem
Terminated
- Inherited Metabolic Disorders (IMD)
- Safety and efficacy assessments
-
Minneapolis, MinnesotaUniversity of Minnesota
Mar 10, 2021
Chronic Kidney Disease(CKD) Trial in Indianapolis (SystemCHANGE (TM), Attention Control)
Enrolling by invitation
- Chronic Kidney Disease(CKD)
- SystemCHANGE (TM)
- Attention Control
-
Indianapolis, IndianaIndiana University School of Nursing
Jun 13, 2022
Cerebral Adrenoleukodystrophy Trial (Mesenchymal Stem Cells)
Withdrawn
- Cerebral Adrenoleukodystrophy
- Mesenchymal Stem Cells
- (no location specified)
Nov 29, 2017
Inherited Metabolic Disorders IMD Trial (Umbilical cord blood transplantation with HSC835)
Withdrawn
- Inherited Metabolic Disorders IMD
- Umbilical cord blood transplantation with HSC835
- (no location specified)
Nov 26, 2018
Hypovitaminosis D, Insulin Resistance, Obesity Trial in Beirut (Euro D and Ci-CalD, Euro D, Ci-CalD)
Completed
- Hypovitaminosis D
- +3 more
- Euro D and Ci-CalD
- Euro D, Ci-CalD
-
Beirut, LebanonAmerican University of Beirut
Nov 19, 2015